ArticleRespirology case reports2025
An Unusual Initial Manifestation of Pulmonary Embolism: Aseptic Cavitary Infarction With Pulmonary Hypertension-Case Report and Literature Review.
Article in Respirology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- An Unusual Initial Manifestation of Pulmonary Embolism: Aseptic Cavitary Infarction With Pulmonary Hypertension-Case Report and Literature Review.Respirology case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare but serious consequence of acute pulmonary embolism occurring in about 0.4%-6.2% of cases. Pulmonary infarction is an infrequent complication due to the lung's dual blood supply. Cavitary pulmonary infarction without infection is an exceedingly rare manifestation in CTEPH. We are reporting a 44-year-old woman who presented with lower limb swelling, cough, haemoptysis, and dyspnoea. Evaluation confirmed CTEPH with an aseptic cavitary infarct in the context of a heterozygous Factor V Leiden (1691G > A) mutation. She responded well to anticoagulation and riociguat, showing marked clinical improvement and complete resolution of the cavity on follow-up imaging. Family screening showed that both children carried the same mutation, highlighting the value of genetic testing in patients with unexplained CTEPH.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.